Kano Therapeutics

The DNA platform for genetic medicine

Kano Therapeutics was founded in 2022, is headquartered in Cambridge, United States, lists 1–10 employees, and has $7.2M in recorded funding across 1 round.

Headquarters
Cambridge
Employees
1–10
Founded
2022
Business Model
B2B
Total Funding
$7.2M
Last Round
$7.2M SeedMay 2024
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

Kano Therapeutics is a Cambridge, Massachusetts biotech developing circular single-stranded DNA (cssDNA) as a next-generation genetic medicine payload, offering a high-fidelity, immune-quiet, and scalable alternative to viral vectors and toxic double-stranded DNA. The platform supports CRISPR-based knock-ins, targeted insertion with recombinase or transposon systems, and non-integrating episomal expression, manufactured at industrial scale via fermentation. Kano partners with cell and gene therapy developers, supplying DNA products from early evaluation through GMP production.

Summary

Kano Therapeutics is a Biotech company based in Cambridge, United States, founded in 2022. It lists 1–10 employees. It has raised $7.2M in total across 1 round, most recently a $7.2M Seed round in May 2024. Investors include The Engine.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundMay 2024
$7.2M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Kano Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/kano-therapeutics"><img src="https://indexed.vc/api/badge/company/kano-therapeutics" alt="Kano Therapeutics on Indexed.vc" width="260" height="76" /></a>